Related by context. All words. (Click for frequent words.) 93 LSE ASM 71 Antisoma plc LSE 71 Combination REOLYSIN R 70 PRNewswire FirstCall Sanofi aventis 70 See BioWorld Today 69 Biological Therapy 69 PRNewswire FirstCall AEterna Zentaris 69 PRNewswire FirstCall YM BioSciences 69 LSE SHP.L 69 Æterna Zentaris Inc. 68 Initiates Enrollment 68 Antisoma plc 68 PRNewswire FirstCall Callisto Pharmaceuticals 68 Inc. Amex KAL 68 Clavis Pharma ASA OSE 68 Abraxis Bioscience Inc. 68 AMEX RGN 68 Provectus Pharmaceuticals specializes 68 Inc. AMEX LIV 67 Initiates Clinical Trial 67 Therapeutic Competitors companiesandmarkets.com adEgemonye 67 & LSE GLPG 67 Inc. TSX AEZ 67 Nasdaq FURX 67 PRNewswire FirstCall Pharmacopeia 67 ExonHit Therapeutics SA 67 IG HCR ;) CO 67 ALLSCHWIL BASEL SWITZERLAND 67 Agios Pharmaceuticals 67 NYSE Amex YMI 67 Vitrasert R 67 PRNewswire FirstCall SuperGen 67 Shire plc LSE SHP 67 NASDAQ SHPGY 67 FoldRx Pharmaceuticals Inc. 67 Evotec AG Frankfurt 67 Inc. AMEX YMI 67 Completes Patient Enrollment 67 Algeta ASA OSE ALGETA 67 pralatrexate injection folate analogue 66 Galapagos NV Euronext 66 Frankfurt XMP 66 CNW YM BioSciences 66 NASDAQ INFI 66 TSX AEZ 66 OTCBB NPHC biotechnology 66 Prednisone Against Refractory 66 CNS Disorders 66 Inc. NASDAQ AEZS 66 Crucell NV NYSE Euronext 66 Nasdaq PCOP 66 Inc. Nasdaq INFI 66 NASDAQ AEZS 66 Oxford BioMedica Plc 66 b3c newswire 66 TSX MGI 66 Amex KAL 66 CLAVIS 66 NEWTOWN Pa. BUSINESS WIRE 66 Initiates Phase III 66 FOLOTYN ® 66 Receives Orphan Drug Designation 66 TARRYTOWN NY BUSINESS WIRE 66 Alternext ALEHT 66 Sanofi aventis EURONEXT SAN 66 Galapagos NV Euronext GLPG 66 MorphoSys AG FSE MOR 66 PRNewswire FirstCall Aeterna Zentaris 66 Nasdaq AEGR 66 Inc. Nasdaq SUPG 66 Oxford BioMedica LSE OXB 66 WILMINGTON NC BUSINESS WIRE 65 PRNewswire FirstCall MannKind 65 PRNewswire FirstCall Amarin 65 PF # [002] 65 OncoGenex Pharmaceuticals Inc. 65 Euronext SAN 65 Quark Pharmaceuticals Inc. 65 TKPHF 65 Novartis VIRT X 65 Hematology Molecular Pathology 65 Drug Shows Promise 65 Durata Therapeutics 65 Inc. NASDAQ AGIX 65 NASDAQ AVII developer 65 Nasdaq IMGN 65 TRACON Pharmaceuticals 65 Euronext Paris Code Isin 65 Astex Therapeutics 65 PRNewswire Anthera Pharmaceuticals 65 Syndax Pharmaceuticals Inc. 65 initiated Phase Ib 65 commercializes oncology 65 Clinical Trials Update 65 Dynepo TM 65 Inc. Nasdaq PARD 65 PRNewswire FirstCall MIGENIX 65 PRNewswire FirstCall Cytokinetics Incorporated 65 Torisel temsirolimus 65 AIM SLN 65 Company Euronext OCTO 65 GLOBE NEWSWIRE Achillion Pharmaceuticals 65 NASDAQ CORT 65 Nasdaq TARG 65 NASDAQ ARRY 65 NASDAQ CRXL 65 Inc. Nasdaq COLY 65 Begins Dosing 65 Nasdaq HALO 65 Nasdaq ACEL 65 Inc. NASDAQ QLTI 65 Namenda Memantine HCl 65 Tibotec BVBA 65 Cancer Patients Treated 65 Xanthus Pharmaceuticals Inc. 65 include ColorectAlert TM 65 Insmed Incorporated NASDAQ INSM 65 Endo Pharmaceuticals Nasdaq ENDP 65 PRNewswire FirstCall Neurogen 65 Nasdaq CYTR biopharmaceutical 65 Brentuximab Vedotin SGN 65 OTCBB URGP specialty 65 Presents Preclinical 65 Inc. OTCBB CYKN 64 Antibody Therapeutics 64 Epeius Biotechnologies Corporation 64 LymphoStat B TM 64 Inc. NASDAQ VSGN 64 Memgen 64 Therapeutic Competitors Companies 64 Ltd. OTCBB IMUC 64 Inc. Nasdaq IDMI 64 Alnylam Nasdaq ALNY 64 PRNewswire FirstCall Poniard Pharmaceuticals 64 Inc. Nasdaq IMGN 64 Amira Pharmaceuticals 64 Auxilium Pharma 64 Aphton Corporation 64 NASDAQ OSIP announced 64 Slows Progression 64 BRANFORD Conn. BUSINESS WIRE 64 Annamycin 64 LungAlert TM 64 Biomarker Study 64 Inc. Lorus biopharmaceutical 64 PRNewswire Shire plc 64 Nasdaq DVAX 64 Tramiprosate ALZHEMED TM 64 Bevacizumab Avastin 64 SHP LN 64 NYSE Amex PTN 64 AEterna Zentaris Inc. 64 Nasdaq OSIP 64 Initiates Phase II 64 Synosia Therapeutics 64 Inc. Nasdaq IDIX 64 Viagra Soft Cialis Soft 64 Inc. Nasdaq AGIX 64 DEERFIELD Ill. BUSINESS WIRE 64 Nasdaq PRAN 64 FDA APPROVES 64 NASDAQ BIIB 64 PRNewswire FirstCall Endocare 64 NYSE Amex RGN 64 Nasdaq MITI biopharmaceutical 64 Modrenal R 64 Diasome Pharmaceuticals 64 NICE Recommends 64 Inc. NASDAQ SUPG 64 TOPIGEN Pharmaceuticals Inc. 64 Nasdaq IDIX 64 Inc. NASDAQ IDIX 64 Nasdaq IDRA 64 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 64 Nasdaq PPHM clinical 64 Agendia BV 64 Nasdaq RDEA 64 Inc. Nasdaq SEPR 64 Nasdaq CRXL 64 Nasdaq ALNY 64 Treatment Shows Promise 64 Crucell NV Euronext 64 humanized therapeutic 64 BLRX 64 PRNewswire FirstCall Rosetta Genomics 64 NASDAQ CXSP announced 64 AMEX IMM 64 ReGen Therapeutics Plc 64 Albugon 64 Temsirolimus 64 Therapeutic Competitors 64 Argenta Discovery 64 commercialize MDV# 64 PRNewswire FirstCall Vical Incorporated 64 Slow Progression 64 Nasdaq KOSP 64 PRNewswire FirstCall Monogram Biosciences 64 Migenix 64 FDA Approves Novel 64 WATERTOWN Mass. BUSINESS WIRE 64 Nasdaq ENZN 64 AVAX Technologies Inc. 63 Phase 2a Trial 63 drug Treanda 63 PRNewswire FirstCall Shire plc 63 Submits Response 63 PRNewswire FirstCall Micromet 63 Inc. NASDAQ SIRT 63 BIIB.O Quote Profile Research 63 NYSE Amex PBTH 63 Nasdaq INGN 63 WATERTOWN Mass. Business Wire 63 VentiRx Pharmaceuticals 63 HER2 Positive 63 related CMV Retinitis 63 Inc. NASDAQ BPAX 63 Safinamide 63 NASDAQ AVNR 63 Inc. Nasdaq IMMU 63 Corp. Nasdaq BSTC 63 Euronext Paris BIO 63 NASDAQ CGEN announced 63 Nasdaq ACHN 63 Medivation Inc 63 Frazer Penn. based 63 Inc. Nasdaq AVRX 63 commercializing oxidized glutathione 63 PRNewswire FirstCall QIAGEN NV 63 Receives Milestone Payment 63 Tel Aviv Stock Exchanges 63 EXTON Pa. BUSINESS WIRE 63 PRNewswire FirstCall VIVUS 63 NASDAQ SOMX specialty 63 Corporation Nasdaq GNBT 63 NYSE Amex HEB 63 Quark Pharmaceuticals 63 CANCER RESEARCH 63 Pharma Merck Serono 63 PRNewswire FirstCall Idenix Pharmaceuticals 63 NYSE Amex RPC 63 midstage clinical 63 www.ucb group.com 63 Liestal Switzerland 63 Mg Usa 63 CARMIEL Israel 63 PRNewswire FirstCall Regeneron Pharmaceuticals 63 Nexavar sorafenib 63 Files IND 63 OSI Tarceva 63 Ixempra 63 Nasdaq MICU 63 Prana Biotechnology Limited 63 Vernalis plc 63 Ceragenix Pharmaceuticals Inc. 63 CAMBRIDGE MA USA 63 Novel Oral 63 non nucleoside inhibitor 63 Javelin Pharmaceuticals AMEX JAV 63 please visit http:/www.vandapharma.com 63 Urigen Pharmaceuticals Inc. 63 PRNewswire FirstCall Favrille 63 About Positron Positron 63 Submits Biologics License Application 63 CeNeS Pharmaceuticals plc 63 NasdaqGM NTEC today 63 NASDAQ OGXI 63 targeted immunotherapies 63 Severe Sepsis 63 NASDAQ ALTH 63 sirtuin inhibitor program 63 PRNewswire FirstCall Allos Therapeutics 63 Therapeutic Competitors Report 63 #/#/# DIAGNOS inc 63 Shows Promise Against 63 approved incretin mimetic 63 Inc. OTCBB ALRX 63 ACADIA Pharmaceuticals 63 Corporation Nasdaq MNKD 63 Nasdaq NBIX 63 PRNewswire FirstCall Sirna Therapeutics 63 SIX RO ROG 63 Acceleron Pharma Inc. 63 Oncolytics TSX ONC 63 Actelion Ltd 63 Vertex hepatitis C 63 nasal calcitonin product 63 Xoma Ltd 63 ATRA IV 63 PRNewswire FirstCall Auxilium Pharmaceuticals 62 PRNewswire FirstCall Isis Pharmaceuticals 62 GLOBE NEWSWIRE LeMaitre Vascular 62 progressive metastatic prostate 62 includes AstraZeneca Accolate 62 Renal Cancer 62 Nasdaq SNSS 62 Therion Biologics 62 NASDAQ AVEO biopharmaceutical 62 resistant hormone refractory 62 OTCBB CGXP 62 DEERFIELD Ill. Business Wire 62 PRNewswire FirstCall NeurogesX 62 NASDAQ ISTA 62 personalized cellular immunotherapy 62 Inc. OTCBB SPRX 62 PAION AG ISIN 62 label Lipofen R 62 Wellstat 62 PRNewswire FirstCall Peregrine Pharmaceuticals 62 NASDAQ INGN 62 Hormone Refractory Prostate Cancer 62 OTCBB IMUC 62 Inc. Nasdaq DCTH 62 Inc. NASDAQ TRMS 62 PRNewswire FirstCall Northwest Biotherapeutics 62 Ohr Pharmaceutical Inc. 62 PRNewswire FirstCall PAREXEL 62 Nasdaq KOSN 62 Pivotal Clinical Trial 62 novel immunotherapies 62 ImmunoCellular Therapeutics Ltd. 62 Initiates Clinical Trials 62 Achieves Primary Endpoint 62 Inc. Nasdaq CRTX 62 NASDAQ BTRX pharmaceutical 62 Inc. NASDAQ ANPI 62 BOTHELL WA Marketwire #/#/# 62 Corporation NASDAQ MNKD 62 AFREZZA TM 62 Arzerra ofatumumab 62 NASDAQ PCYC 62 Omeros Corporation 62 Bucindolol 62 Inotek Pharmaceuticals Corporation 62 AAG geldanamycin analog 62 SOPHIA ANTIPOLIS France 62 Immunotherapeutic 62 Inc. Nasdaq BIOD 62 Inc. Nasdaq ANTH 62 PRNewswire FirstCall Coley Pharmaceutical 62 Dyax NASDAQ DYAX 62 MBX TSX 62 Meets Primary Endpoint 62 NYSE Amex RNN 62 plc LSE SHP 62 Aflibercept 62 Combivir Kivexa 62 Inc. NASDAQ CBST 62 NASDAQ SCRX specialty 62 PRNewswire FirstCall Immunomedics 62 Nasdaq BSTE 62 Newly Diagnosed Patients 62 Metabasis Therapeutics Inc. 62 NASDAQ CLSN 62 Vaccine Protects Against 62 thetreatment 62 kidney urologic 62 dasatinib Sprycel 62 CIMZIA r 62 ELADUR ™ 62 IntrinsiQ LLC 62 Pepscan Therapeutics 62 PRNewswire FirstCall NicOx SA 62 MIND CTI LTD 62 Inc. Nasdaq TPTX 62 CNW Telbec AEterna Zentaris 62 REGENERX BIOPHARMACEUTICALS INC. 62 Announces Poster Presentations 62 Drug Candidate 62 Aton Pharma Inc. 62 platform HDL Mimetic 62 Nasdaq REGN 62 Martinsried Germany 62 Bayer HealthCare Onyx Pharmaceuticals 62 PRNewswire Chimerix 62 Therapeutics TCT scientific 62 Inc. Nasdaq ONXX 62 OTCBB PYTO 62 Adjuvant Treatment 62 Sopherion Therapeutics 62 GlaxoSmithKline plc GSK 62 TSX BRA 62 rasagiline tablets 62 Pharmion Corporation 62 Abstract Accepted 62 COPPELL Texas BUSINESS WIRE 62 Naive Patients 62 OTCQB CTIX 62 Presents Positive 62 Transgene SA 62 SWX RO SWX ROG 62 gastrointestinal stromal 62 INSPIRE Trial Phase III 62 OMRIX Biopharmaceuticals 62 FORMA Therapeutics 62 Drug Fails 62 Immunomedics Announces 62 OTCBB NRGX 62 DANVERS Mass. BUSINESS WIRE 62 EOS NASDAQ MELA 62 Ascenta Therapeutics 62 Plc SHP LN 62 PRNewswire FirstCall Delcath Systems 62 Nasdaq GNTA 62 PRNewswire FirstCall Angiotech Pharmaceuticals 62 Arimidex anastrozole 62 Neulasta R 62 Institute DFCI 62 Callisto Pharmaceuticals Inc. 62 Vaccine Adjuvant 62 refractory chronic lymphocytic 62 Nektar Therapeutics NKTR 62 NASDAQ ONXX 62 Inc. www.micromet inc.com 62 Avanir Pharmaceuticals Inc 62 Crucell NV NASDAQ CRXL 62 Psoriasis Drug 62 NASDAQ IMCL global 62 NASDAQ ARIA 62 Actress Annette Funicello 62 Nasdaq ACAD 62 Sanofi aventis NYSE SNY 62 Inc. Nasdaq MITI 62 Alemtuzumab 62 NASDAQ CGEN 62 Nasdaq SPPI 62 NASDAQ LGND 61 candidates Azedra TM 61 Mersana Therapeutics 61 Paris IPN Euronext 61 NASDAQ PRAN ASX PBT 61 Onyx Pharmaceuticals Inc 61 PRNewswire FirstCall Spherix Incorporated 61 GLOBE NEWSWIRE Nabi Biopharmaceuticals 61 Receives CE Marking 61 Introgen Therapeutics Inc. 61 Patient Treated 61 Idun Pharmaceuticals 61 Inc. Nasdaq RNAI 61 Submits NDA 61 SCIB1 61 oncolytic virus therapies 61 PRNewswire FirstCall Cell Genesys 61 Vertex Pharmaceuticals NASDAQ VRTX 61 WALTHAM Mass. ImmunoGen 61 BUFORD Ga. BUSINESS WIRE 61 Romiplostim 61 Tetraphase Pharmaceuticals 61 GILD GILD 61 Acorda Therapeutics Inc 61 NASDAQ IMCL 61 Oncothyreon NASDAQ ONTY 61 NASDAQ CLDX 61 Nasdaq ISTA 61 PRNewswire FirstCall Integrated BioPharma 61 PRNewswire FirstCall Pharmasset 61 Inc. NASDAQ MRNA 61 evaluating tivozanib 61 cetuximab Erbitux 61 OTC BB PVCT 61 Nutra Pharma wholly owned 61 Mesoblast Limited ASX MSB 61 NeurAxon Inc. 61 Celsion Corporation 61 pharmacogenomic translational research 61 InVivo Therapeutics Corporation 61 Corporation Nasdaq CRGN 61 Investigational Treatment 61 NASDAQ ABII 61 Genaera Corporation 61 PRNewswire FirstCall Digene 61 TELINTRA R 61 GVAX ® 61 LEXINGTON Mass. BUSINESS WIRE 61 GLOBE NEWSWIRE Emisphere Technologies 61 Initiate Clinical Trial 61 Stock Exchange EVT 61 Treatment Reduces 61 OTCBB NPHC 61 5 lipoxygenase activating 61 Nasdaq PPHM 61 Inc. Nasdaq KERX 61 NYSE Amex AEN 61 AMEX NVD specialty 61 Adenosine Therapeutics 61 Pierre Fabre SA 61 Vidaza azacitidine 61 Gene Mutation Linked 61 Successfully Treats 61 Inc. Nasdaq VVUS 61 Immunomedics Inc. 61 RNVS 61 Nasdaq CLDX 61 Arpida SWX ARPN 61 phase III isavuconazole 61 please visit http:/www.atherogenics.com 61 LARCHMONT NY BUSINESS WIRE 61 J Am Acad 61 Vidaza R 61 PRNewswire FirstCall Kensey Nash 61 PRNewswire FirstCall Alfacell Corporation 61 Avila Therapeutics 61 Inc. NASDAQ SGEN 61 Brussels THR 61 BUSINESS WIRE Jan 61 Colorectal Cancer CRC 61 Adventrx Pharmaceuticals 61 Canvaxin 61 GLAXOSMITHKLINE 61 Amylin Pharmaceuticals Inc AMLN.O 61 commercialize deforolimus 61 NASDAQ INHX 61 Inc. Nasdaq VNDA 61 PRNewswire FirstCall Generex Biotechnology 61 Telik logo TELINTRA 61 Nasdaq CM CRTX 61 Initiates Dosing 61 Hedgehog Pathway 61 developing Zerenex ferric 61 Epiphany Biosciences 61 Enzon Pharmaceuticals Inc 61 PRNewswire FirstCall NeoStem 61 Onglyza saxagliptin 61 Genome Therapeutics 61 Ikaria Holdings Inc. 61 Testim ® topical 61 OTCBB ILNS 61 Nasdaq AMGN 61 Inc. Nasdaq AMLN 61 Corp. NASDAQ PSDV 61 WAUKEGAN Ill. BUSINESS WIRE 61 Nasdaq OMER 61 Rheumatoid Arthritis Drug 61 Nasdaq NPSP announced 61 Selective Electrochemical Tumor Ablation 61 NASDAQ SHPGY TSX SHQ 61 Inc. OTCBB SYBD 61 PRNewswire ACCESS PHARMACEUTICALS 61 KuDOS 61 memantine HCl 61 Adherex Technologies 61 #:#-#,# CrossRef Medline [002] 61 Nicotine Vaccine 61 Completes Patient Enrolment 61 tin ib targets 61 RegeneRx Biopharmaceuticals Inc. 61 Regado Biosciences 61 NASDAQ SCRX 61 Noscira 61 Veridex LLC 61 OTCBB OHRP 61 Inc. NASDAQ BIOC 61 Preclinical Study 61 Aerie Pharmaceuticals 61 Medicis NYSE MRX 61 treat nicotine addiction 61 NASDAQ OMX Nordic ACTI 61 iloprost Inhalation Solution 61 Inc. Nasdaq ATHX 61 ® darbepoetin alfa 61 OncoVex 61 Protalix BioTherapeutics Inc 61 R lenalidomide 61 TAMPA FL eMediaWorld 61 Cancer Incidence Mortality 61 gastro intestinal inflammation 61 Inc. Nasdaq ELGX 61 Nasdaq IMMU 61 Plenaxis 61 Hematological Malignancies 61 Cotara ® 61 cause mesothelioma asbestosis 61 Inc. NASDAQ ORXE 61 s crizotinib ZAH 61 deCODE ProstateCancer TM 61 commercialize SGN 61 NYSE PFE Exelon Rivastigmine 61 Cyclacel Pharmaceuticals 61 Foundation ADDF 61 Reports Preclinical Data 61 PRNewswire FirstCall Nastech Pharmaceutical 61 NASDAQ TGEN 61 ChemGenex Pharmaceuticals Limited 61 Advancis Pharmaceutical Corporation 61 NASDAQ IDEV 61 AMEX REX 61 OTCBB INSV 61 Am J Obstet 61 #-# Full Text 61 Presents Positive Preclinical 61 Saladax Biomedical 61 PRNewswire FirstCall ACCESS PHARMACEUTICALS 61 Barrier Therapeutics Inc. 61 relapsing remitting MS RRMS 61 Nasdaq VRTX 61 Genes Identified 61 Febuxostat 61 Genocea Biosciences 61 Drug Combo 61 Dynavax Technologies Corporation 61 Bayer Nexavar 61 Intercept Pharmaceuticals 61 Inc. Nasdaq PPHM 61 R sorafenib tablets 61 Salmedix 61 Regeneron Pharma 61 Inc. Nasdaq SGXP 61 Rebif interferon beta 1a 61 NasdaqCM PSTI DAX PJT 61 SWX ATLN announced 61 Asthma COPD 61 Interferon beta 1a 61 Novartis Femara 61 Daclizumab 61 PRNewswire FirstCall Viragen 61 Guidelines Recommend 61 Ceflatonin R 61 HuMax TAC 61 Teikoku Pharma USA 61 Inc. NASDAQ HEPH 61 Nasdaq PARD 61 Vertex Pharmaceuticals Inc 61 OTCBB VCRT 61 Protherics PLC 61 Ingelheim Germany 60 Biomoda www.biomoda.com 60 Optimer Pharmaceuticals Inc 60 AMEX YMI 60 Temodar ® 60 Lung Cancer Drug 60 Patient Enrolment 60 Astex Therapeutics Limited 60 Inc. Nasdaq RNVS 60 Adrenomyeloneuropathy AMN HIV 60 NASDQ ROSG 60 Oxford Genome Sciences 60 OTCBB NVLT biopharmaceutical 60 Alteplase 60 Akebia Therapeutics 60 Vaccine Immunology 60 Idera Pharmaceuticals 60 Magen BioSciences 60 NASDAQ CYTX 60 Alnara Pharmaceuticals 60 SinuNase ™ 60 Ercole Biotech 60 AMEX DDD 60 Selecta Biosciences Inc. 60 Satori Pharmaceuticals 60 Ocular Diseases 60 NASDAQ OSIR 60 Exploit collaboration 60 customizable drug eluting 60 Clavis Pharma ASA 60 Initiates Clinical 60 Bioenvision Nasdaq BIVN 60 Corp. Nasdaq GENZ 60 AACR #st Annual Meeting 60 Nasdaq CYCC 60 Supergen 60 NASDAQ ISIS 60 Nasdaq QGEN 60 PRNewswire FirstCall Anadys Pharmaceuticals 60 Chroma Therapeutics 60 Multiple Sclerosis Rheumatoid Arthritis 60 INDICATED HIGHER 60 Marillion Pharmaceuticals 60 NicVAX TM 60 Reuters GlaxoSmithKline Plc 60 Bryan Cranston portrayal 60 Inspire Pharmaceuticals Inc 60 INC. TSX YRI 60 Inc. Nasdaq ACHN 60 Vicriviroc 60 TSX DND 60 Maven Semantic 60 Inc. OTCBB CADM 60 CRMD pharmaceutical 60 Inc. Nasdaq SVNT 60 Inc. Nasdaq ANDS 60 ImClone Systems Incorporated 60 Gentamicin Surgical Implant 60 Critical Therapeutics Zyflo 60 OTCBB QTXB 60 PRNewswire FirstCall YAMANA GOLD 60 Adherex Technologies Inc. 60 NASDAQ TARG 60 OTCBB IMNR 60 Nasdaq ALTH 60 AstraZeneca AZN.L 行情 60 Platinum Resistant Ovarian 60 Nasdaq AUXL 60 Hedgehog Pathway Inhibitor 60 MD Moross Institute 60 Phase #b/#a clinical 60 LYON France Business Wire 60 GlaxoSmithKline Tykerb 60 Azacitidine 60 acadesine 60 Corixa Corporation 60 YM AIM YMBA 60 DJO Incorporated 60 AstraZeneca Plc AZN LN 60 Corporation Nasdaq KNSY 60 Nasdaq ANPI 60 ALSO CALLED 60 Granted Orphan Drug 60 telomerase therapeutic 60 Inc. NASDAQ AGEN 60 EORTC NCI 60 Inc. Nasdaq REGN 60 YM BioSciences Inc. 60 Nasdaq CGEN 60 Phase 2b Clinical Trial 60 Melior Discovery 60 Nasdaq SCLN 60 Epix Pharmaceuticals 60 osteolytic bone disease 60 Eribulin 60 Celldex Therapeutics NASDAQ CLDX 60 Romidepsin 60 Orthop Surg 60 NSE SUNPHARMA 60 Hepatocellular 60 Inc. Nasdaq LXRX 60 Investorideas.com newswire BioSante PharmaceuticalLarne Holyhead 60 Related Disorders ICAD 60 NASDAQ AXCA 60 CRYO 60 Idenix Pharmaceuticals 60 TetraLogic Pharmaceuticals 60 Pruvel TM 60 Nasdaq IDEV 60 Cholesterol lowering statin 60 fluorinated carbohydrate mimics 60 PRNewswire FirstCall CEL SCI 60 Tranzyme Pharma 60 OTCBB UGNE http:/www.unigene.com 60 gastrin analogue TT 60 Nasdaq NPSP 60 Bionomics Limited 60 TRANSDUR ® 60 NASDAQ IMMU 60 Gendux AB 60 Pirespa 60 Molecular Diagnostic Test 60 OctoPlus NV OctoPlus 60 Electro Optical Sciences 60 Osmetech plc 60 vinorelbine tartrate 60 AB OMXS BINV 60 Nasdaq EXAS 60 CeNeRx BioPharma 60 Inc. NASDAQ ONTY 60 HAWTHORNE Calif. BUSINESS WIRE 60 Am J Geriatr 60 Patients Treated With 60 Transdermal Patch 60 CRIME TIME 60 Randomized Phase 60 MBRX 60 ALTROPANE R 60 Collegium Pharmaceutical Inc. 60 Nasdaq OSCI 60 Sprycel dasatinib 60 Ligand Pharmaceuticals NASDAQ LGND 60 Known generically 60 Fulvestrant 60 Pulmo BioTech Inc. 60 Nasdaq ACOR 60 DOI #.#/hep.# 60 ROCKVILLE Md. Business Wire 60 NASDAQ ONCY 60 PRNewswire FirstCall Cellegy Pharmaceuticals 60 brivanib 60 Plethora Solutions Holdings 60 Mpex Pharmaceuticals 60 thalidomide Thalomid 60 Inc. Nasdaq FVRL 60 DVT prophylaxis cholesterol 60 metastatic colorectal 60 Alimta pemetrexed 60 Serdolect ® 60 MISSISSAUGA Ontario BUSINESS WIRE 60 Inc. Nasdaq CLRT 60 Traversa Therapeutics 60 Teva Provides Update 60 CTI OTCBB CHKT 60 NASDAQ SNTA biopharmaceutical 60 ViroPharma Incorporated Nasdaq VPHM 60 RANK Ligand inhibitor 60 VANTAS ® 60 Nasdaq CYTX 60 investigational oral inhibitor 60 Crofelemer budesonide foam 60 Nasdaq BIIB 60 #-# Lazelle Ave 60 Anticancer Drug 60 Biogen Genentech 60 PRNewswire FirstCall OncoGenex Pharmaceuticals 60 ThermoDox R 60 Merck Serono Nycomed 60 Endocrinol 60 NASDAQ DADE 60 Dementia Related Psychosis 60 CYT# potent vascular disrupting 60 TSX TKM 60 Inc. Nasdaq OXGN 60 WARSAW Ind. BUSINESS WIRE 60 Tokai Pharmaceuticals 60 Abviva Inc. 60 Kinase Inhibitor 60 KAI Pharmaceuticals Inc. 60 phase IIb trial 60 Completes Dosing 60 Empatic ™ 60 NASDAQ QCOR 60 Javelin applies 60 Etravirine 60 Othera Pharmaceuticals Inc. 60 Inc. Nasdaq ALTH 60 Successfully Treated 60 Patient Enrollment 60 fighter Lipitor impotence 60 OTCBB EMIS 60 mitoxantrone plus 60 Investigational Compound 60 Ltd. CHTP 60 MKC# MKC# PP 60 MELBOURNE AUSTRALIA Marketwire 60 IAP inhibitor 60 FDA Approves Drug 60 Therapeutic Approaches 60 Response Genetics Inc. 60 Trodusquemine MSI 60 Nymox Pharmaceutical 60 OTCBB HPLF 60 Tesmilifene 60 GSK.L Quote Profile Research 60 TRANSDUR ™ 60 Aricept donepezil 60 NASDAQ MELA 60 CE marked PROGENSA 60 Inc. Nasdaq INSM 60 Onko Sure TM 60 Sutent sunitinib malate 60 markets HP Acthar 60 Amedica Corporation 60 PHRM 60 Nasdaq IDRA today 60 J Allergy Clin 60 Vical Incorporated Nasdaq VICL 60 PRNewswire FirstCall Pressure BioSciences 60 SIX ATLN 60 IRIDEX Corporation 60 Therapeutics TCT 60 BioProgress plc 60 4SC AG ISIN DE# 60 orally inhaled migraine 60 Peptide YY 60 AUDIO PROVIDED BY 60 intrahepatic bile duct 60 Inc. NASDAQ ACUS 60 Nasdaq ETWC leading 60 Advanced Melanoma 60 Dicerna Pharmaceuticals Inc. 60 Mg Uk 60 untreated metastatic pancreatic 60 Amgen Neulasta R 60 Reata Pharmaceuticals 60 Inc. NASDAQ MGRM 60 Breast Cancer Recurrence 60 Eyetech Pharmaceuticals 60 Wadih Arap 60 Accentia Biopharmaceuticals 60 Ovation Pharmaceuticals Inc. 60 Basilea Toctino R 60 Cochrane Database Syst Rev. 60 Initiate Phase 60 LENALIDOMIDE 60 Hsp# Inhibitor 60 Cethrin R 60 Prolongs Survival 60 MEDA AB publ 60 Quark Biotech 59 Raptiva R 59 Oncothyreon Inc 59 Gonal f R follitropin 59 Bone Marrow Transplants 59 OTCBB CVBT 59 Degarelix 59 Locked Nucleic Acid 59 J Clin Endocrinol Metab 59 Nasdaq VICL 59 NASDAQ ALNY 59 Viread tenofovir disoproxil fumarate 59 Xenoport Inc. 59 hematological cancers notably 59 treat gastrointestinal disorders 59 Oral Suspension USP 59 Seattle Genetics SGEN 59 Discoveries Tomorrow 59 Molecular Cancer 59 Syntonix Pharmaceuticals 59 Nasdaq CADX 59 NASDAQ PGNX 59 OTCBB ARDM 59 Launches Generic Version 59 Nereus Pharmaceuticals 59 Nasdaq SPEX 59 deCode genetics 59 ABI OTCBB AMAR 59 liver resection surgeries 59 Corporation Nasdaq GENR 59 BEDMINSTER NJ Business Wire 59 RNAi Therapeutic 59 Healthnostics Inc. 59 ImmunoGen TAP technology 59 combines Zetia 59 Nasdaq ICOS 59 Vion Pharmaceuticals 59 Fortical ® 59 SWISS BSLN 59 Silodosin 59 NASDAQ SLXP 59 InfaCare Pharmaceutical Corporation 59 Gastrointestinal Oncology 59 ovarian prostate 59 AstraZeneca Plc AZN.L 59 Amex ANX 59 Merv Griffin Dies 59 SACRE COEUR MINERALS LTD 59 attach auristatin 59 Risperidone Oral Solution 59 Nasdaq AVAN 59 MEK Inhibitor 59 AIM OBP 59 Personalized Immunotherapy 59 NASDAQ VRTX 59 PRNewswire FirstCall Neurocrine Biosciences 59 Phase Ib IIa 59 BY MARK BELL 59 NASDAQ TRBN 59 accumulate preferentially 59 Neglected Diseases initiative 59 liposomal delivery 59 Nasdaq AEZS 59 Board NGNM 59 cause cardiac channelopathies 59 Archemix Corp. 59 Receives Orphan Drug 59 Plexxikon proprietary 59 Cerenis Therapeutics 59 EnVivo Pharmaceuticals 59 BSX COV leading 59 AN# topical anti 59 Nasdaq RGDX 59 Malignant Melanoma 59 Nasdaq RGEN 59 PRNewswire FirstCall Genta Incorporated 59 Kosan dependence 59 FDA Okays 59 Nasdaq GNBT 59 Node Positive 59 Humira adalimumab 59 NASDAQ EPIX 59 Schering AG SCHG.DE 59 QuatRx Pharmaceuticals 59 Completes Enrollment 59 R Saizen R 59 Phase III Clinical Trial 59 Anti Angiogenesis 59 Cancer iSBTc 59 Nasdaq VRTX today 59 Cubist Pharmaceuticals Inc 59 Kinase Inhibitors 59 & Rheumatism journal 59 Eloxatin oxaliplatin 59 Inc. Nasdaq ONTY 59 SYN X 59 Cytori NASDAQ CYTX 59 PLX MS 59 Lowers Risk 59 First Patient Enrolled 59 Anchor Therapeutics 59 Integrase Inhibitor 59 adalimumab Humira 59 NASDAQ DCTH 59 Previously Treated 59 NASDAQ PANC biotechnology 59 brand ciclesonide HFA 59 CHDI Foundation 59 Cenix BioScience 59 R memantine HCl 59 Shows Promising 59 EPIX Pharmaceuticals Inc. 59 Recurrent Breast Cancer 59 Gene Linked 59 Nasdaq AMLN 59 Inc. Nasdaq ALNY